Clinical Trial Update: A Study to Investigate the Long-term Safety and Efficacy of Tolvaptan in Patients With Autosomal Dominant Polycystic Kidney Disease (ADPKD) [Extension of Trial 156-04-251 in Japan] [Phase 3]

View source ↗

Summary

This clinical trial update reports long-term safety and efficacy results from an extension of a Phase 3 study of tolvaptan in autosomal dominant polycystic kidn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Autosomal Dominant Polycystic Kidney Disease （ADPKD) | Phase 3 | Status: COMPLETED | Results posted: 2019-01-17